Attorney General R Venkatramani and Justice D N Patel will present their views on simultaneous election bills to a parliamentary committee....

Bullish ABC breakout suggests follow through moves on P&F chart.

Stock price is in an attempt of decisive upside break-out of resistance of top of Nov at Rs 454 levels.

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Phar...

Promoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.

The brokerage has raised earnings estimates by 2-10% to reflect the strong earnings beat in the third quarter.

The analyst suggested a stoploss at Rs 250.

The analyst suggested a stoploss at Rs 245.

If appointed interim head, Vishwanathan would head the central board meeting scheduled this Friday, the sources said.

Sell Cadila Healthcare Ltd. at a price target of Rs 373.0 and a stop loss at Rs 402 from entry point.

Buy Cadila Healthcare Ltd. at a price target of Rs 435.0 and a stop loss at Rs 419 from entry point.

Sell Cadila Healthcare at a price target of Rs 445 and a stop loss at Rs 470 from entry point.

Buy IRB Infrastructure Developers Ltd. at a price target of Rs 261.0 and a stop loss at Rs 230.0 from entry point

The collection will be a reprint of the volumes that were compiled from various journals and periodicals tracing Patel's life from 1918.

While in power the NDA government mooted the plan for a Sardar Patel Memorial on the lines of Nehru Memorial Museum & Library (NMML).

Amid a raging row on two prime South Delhi properties gifted by IFFCO to its top executives, its Managing Director U S Awasthi and his depu...

Earth Refining Company (P) Ltd, with majority stake in joint venture, is exploring possibility of about 26% equity from Gujarat Mineral Dev...